북미의 안약 시장 예측 - 지역별 분석 : 유형, 용도, 구입 형태별(2030년)

The North America eye drops market is expected to grow from US$ 8,030.88 million in 2022 to US$ 12,289.12 million by 2030. It is estimated to grow at a CAGR of 5.5% from 2022 to 2030.

Rising Prevalence of Ophthalmic Diseases Fuels North America Eye Drops Market

The incidence of ophthalmic diseases such as diabetic retinopathy, glaucoma, and dry eye leading to vision impairment is rising among the population, especially in developed countries. A dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. According to a study, "National Health and Wellness Survey," conducted in the US in April 2020, ~16.4 million people were diagnosed with dry eye. The data also stated that the prevalence had surged by 2.7% among people aged 18-34 years. According to Novaliq GmbH, ~17 million Americans currently suffer from dry eye disease.

Diabetic retinopathy represents microvascular end-organ damage. It progresses from non-proliferative diabetic retinopathy stages to proliferative diabetic retinopathy. As the disease progresses, associated diabetic macular edema may also become apparent. According to an article published by the American Academy of Ophthalmology, it is estimated that by 2030 an estimated 191 million people globally will suffer from diabetic retinopathy. According to Medscape, ~700,000 people in the US suffer from proliferative diabetic retinopathy, with ~65,000 new cases recorded annually.

According to an article published by the World Health Organization (WHO) in 2022, ~2.2 billion people worldwide suffer from near or distant vision impairment. The leading causes of vision impairment are cataracts (~94 million cases) and uncorrected refractive errors (~88.4 million cases). Doctors generally prescribe eye drops for the treatment and prevention of ophthalmic diseases. Hence, the increasing prevalence of ophthalmic diseases is fueling the growth of the North America eye drops market .

North America Eye Drops Market Overview

The North America eye drops market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising awareness of dry eye conditions, an increase in the aging population, and technological advancements in eye treatment procedures with the rising incidence of eye disorders. Dry eye disease is a common but underdiagnosed condition in the US. The growing geriatric population further triggers the prevalence of dry eye disease. According to the Centers for Disease Control and Prevention (CDC), age-related eye diseases such as macular degeneration, cataract, diabetic retinopathy, and glaucoma are the leading causes of blindness and low vision in the US. Other common eye disorders reported in the country include amblyopia and strabismus. With aging populations and the increased frequency of younger adults receiving refractive surgeries, dry eye is expected to affect as many as 2.79 million men in the US by 2030.

The US is the largest and fastest-growing country in the North America eye drops market. The market in this country is ascribed to the increasing incidence of dry eye disease among people. Various companies offering different eye drops and lenses to treat dry eye condition have presence in the US. Also, the rising healthcare expenditure favors the growth of the North America eye drops market in the US.

North America Eye Drops Market Revenue and Forecast to 2030 (US$ Million)

North America Eye Drops Market Segmentation

The North America eye drops market is segmented into type, application, purchase mode, and country.

Based on type, the North America eye drops market is segmented into antibiotics, artificial tears, hormones, and others. The antibiotics segment held the largest share of the North America eye drops market in 2022.

Based on application, the North America eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment held the largest share of the North America eye drops market in 2022. The eye diseases segment is further segmented into dry eye, glaucoma, cataract, and others.

Based on purchase mode, the North America eye drops market is segmented into OTC and prescription. The prescription segment held a larger share of the North America eye drops market in 2022.

Based on country, the North America eye drops market is segmented into the US, Canada, and Mexico. The US dominated the North America eye drops market in 2022.

AbbVie Inc, Akorn Operating Company LLC, Alcon AG, Bausch & Lomb Inc, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, and Similasan Corp are some of the leading companies operating in the North America eye drops market.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Eye Drops Market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the North America Eye Drops Market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

Table of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. North America Eye Drops Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
  • 4.2.1 North America PEST Analysis
• 4.3 Pipeline Analysis
• 4.4 Purchase Mode

5. North America Eye Drops Market - Key Industry Dynamics

• 5.1 Market Drivers
  • 5.1.1 Rising Prevalence of Ophthalmic Diseases
  • 5.1.2 High Incidence of Age-Related Eye Diseases
• 5.2 Market Restraints
  • 5.2.1 Product Recalls
• 5.3 Market Opportunities
  • 5.3.1 Rising Initiatives for Eye Care
• 5.4 Future Trends
  • 5.4.1 Changing Lifestyle
• 5.5 Impact Analysis

6. Eye Drops Market - North America Market Analysis

• 6.1 North America Eye Drops Market Revenue (US$ Mn), 2022 - 2030

7. North America Eye Drops Market - Revenue and Forecast to 2030 - by Type

• 7.1 Overview
• 7.2 North America Eye Drops Market Revenue Share, by Type 2022 & 2030 (%)
• 7.3 Antibiotics
  • 7.3.1 Overview
  • 7.3.2 Antibiotics: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Artificial Tears
  • 7.4.1 Overview
  • 7.4.2 Artificial Tears: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Hormones
  • 7.5.1 Overview
  • 7.5.2 Hormones: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Others
  • 7.6.1 Overview
  • 7.6.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Eye Drops Market - Revenue and Forecast to 2030 - by Application

• 8.1 Overview
• 8.2 North America Eye Drops Market Revenue Share, by Application 2022 & 2030 (%)
• 8.3 Eye Diseases
  • 8.3.1 Overview
  • 8.3.2 Eye Diseases: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.1 Dry Eye
      • 8.3.2.1.1 Overview
    • 8.3.2.2 Dry Eye: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.3 Glaucoma
      • 8.3.2.3.1 Overview
      • 8.3.2.3.2 Glaucoma: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.4 Cataract
      • 8.3.2.4.1 Overview
      • 8.3.2.4.2 Cataract: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.5 Others
      • 8.3.2.5.1 Overview
      • 8.3.2.5.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Eye Care
  • 8.4.1 Overview
  • 8.4.2 Eye Care: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Others
  • 8.5.1 Overview
  • 8.5.2 Others: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Eye Drops Market - Revenue and Forecast to 2030 - by Purchase Mode

• 9.1 Overview
• 9.2 North America Eye Drops Market Revenue Share, by Purchase Mode 2022 & 2030 (%)
• 9.3 Prescription
  • 9.3.1 Overview
  • 9.3.2 Prescription: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 OTC
  • 9.4.1 Overview
  • 9.4.2 OTC: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Eye Drops Market - Revenue and Forecast to 2030 - Country Analysis

• 10.1 North America Eye Drops Market
  • 10.1.1 Overview
    • 10.1.1.1 US: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.1.1 Overview
      • 10.1.1.1.2 US: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.1.3 US: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
      • 10.1.1.1.4 US: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.1.4.1 US: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
      • 10.1.1.1.5 US: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
    • 10.1.1.2 Canada: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.2.1 Overview
      • 10.1.1.2.2 Canada: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.2.3 Canada: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
      • 10.1.1.2.4 Canada: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.2.4.1 Canada: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
      • 10.1.1.2.5 Canada: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)
    • 10.1.1.3 Mexico: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.3.1 Overview
      • 10.1.1.3.2 Mexico: North America Eye Drops Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.1.3.3 Mexico: North America Eye Drops Market, by Type, 2020-2030 (US$ Million)
      • 10.1.1.3.4 Mexico: North America Eye Drops Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.3.4.1 Mexico: North America Eye Drops Market, For Eye Diseases by Application, 2020-2030 (US$ Million)
      • 10.1.1.3.5 Mexico: North America Eye Drops Market, by Purchase Mode, 2020-2030 (US$ Million)

11. North America Eye Drops Market-Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the Eye Drops Market (%)
• 11.3 Organic Developments
  • 11.3.1 Overview
• 11.4 Inorganic Developments
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Akorn Operating Company LLC
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Alcon AG
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 Pfizer Inc
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Prestige Consumer Healthcare Inc.
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Rohto Pharmaceutical Co Ltd
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Similasan Corp
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 AbbVie Inc
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Bausch & Lomb Inc
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments

13. Appendix

• 13.1 About Us
• 13.2 Glossary of Terms